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Abstract
Background: There is evidence for an adaptive role of the omega -3 fatty acid, docosahexaenoic acid
(DHA) during stress. Mechanisms of action may involve regulation of stress mediators, such as the
catecholamines and proinflammatory cytokines. Prevention of stress-induced aggression and hostility were
demonstrated in a series of clinical trials. This study investigates whether perceived stress is ameliorated
by DHA in stressed university staff.
Methods: Subjects that scored ≥ 17 on the Perceived Stress Scale were randomised into a 6-week pilot
intervention study. The diet reactive group was supplemented with 6 g of fish oil containing 1.5 g per day
DHA, while the placebo group was supplemented with 6 g a day of olive oil. The groups were compared
with each other and a wider cross sectional study population that did not receive either active or placebo
intervention.
Results: There was a significant reduction in perceived stress in both the fish oil and the placebo group
from baseline. There was also a significant between-group difference between the fish oil group and the
no-treatment controls in the rate of stress reduction (p < 0.05). However, there was not a significant
between-group difference between the fish oil and the placebo group, nor the placebo group and the
control group.
These results are discussed in the context of several methodological limitations. The significant stress
reductions in both the fish oil and the placebo group are considered in view of statistical regression, an
effect likely to have been exaggerated by the time course of the study, a large placebo effect and the
possibility of an active effect from the placebo.
Conclusion: There were significant differences (p < 0.05) in the fish oil group compared with no-
treatment controls. This effect was not demonstrated in the placebo group. As a pilot study, it was not
sufficiently powered to find the difference between the fish oil group and the placebo group significant.
Further work needs to be undertaken to conclusively demonstrate these data trends. However, the
findings from this research support the literature in finding a protective or 'adaptogenic' role for omega-3
fatty acids in stress.
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Background
Rousseau and Moreau et al [1] demonstrated an amelio-
rated cardiac response to a mild socio-social stress in DHA
(the omega-3 fatty acid, docosahexaenoic acid) fed rats.
The feeding schedule induced mild increases in heart rate
in the sunflower oil fed group but not the DHA group. A
corresponding increase in norepinephrine was significant
only in the sunflower oil group. DHA also decreased
systolic and diastolic blood pressure. The beneficial cardi-
ovascular alterations, evident within a few weeks of sup-
plementation, corresponded with high cardiac
phospholipid membrane levels of DHA found on post-
mortem examination.
Mills and Prkachin et al [2] found an effect from borage oil
(found to rapidly increase membrane dGLA, the omega-6
dihomogammalinolenic acid) but not fish oil (rich in
DHA) in cardiac parameters of stress reactivity in humans.
Unfortunately, the potential confounds were not ade-
quately discussed, bringing into question the reliability of
these results. For instance, there was no mention of sub-
ject withdrawals or dropouts, a flush-out period, back-
ground diets, or background stress levels. Chronic stress
levels have subsequently been demonstrated to influence
reactivity to an acute stressor [3] and the effectiveness of
DHA to reduce stress [4].
A research group in Japan have shown a protective effect
of DHA during stress. A multi-centred randomised, pla-
cebo-controlled, double blind study involving 53 medical
students and 3 months supplementation with 1.5 g/d was
timed to coincide with a period of intense stress. They
found that aggression towards others was significantly
increased in the control group by 8.9% from baseline (p <
0.007) during the final examinations. There was no differ-
ence in aggression in the DHA group [5]. DHA prevented
an increase in aggression during the examination period.
The second study was modelled on the previous study
with the major difference being timing [6]. A similar but
non-stressed sample 46 of university students were tested
for aggression. The second study was designed to not coin-
cide with any periods of academic stress. It commenced at
the start of the summer holidays. The researchers found
that DHA does not affect aggression of normal volunteers
under non-stressful conditions.
Hostility was also found to increase significantly during
psychological stress[7]. In a randomised, placebo-control-
led, double blind study, 41 students took either 1.5 g/d
DHA or placebo (soy oil) for 3 months. Hostile responses
were significantly increased by from 27% (baseline) to
92% (during exams) in the control group, where there
were no significant changes in the DHA group (p < 0.01).
There were highly significant between-group differences
(p < 0.002). The same researchers demonstrated that hos-
tility levels significantly decreased in a population of uni-
versity staff taking DHA supplementation compared with
no change in hostility levels in subjects taking the placebo
[7]. DHA appears to have an adaptive effect on hostility.
Sawazaki and Hamazaki et al [8] investigated the effect of
DHA on various physiological parameters during psycho-
logical stress. Fourteen medical students took either 1.5 g/
d DHA or placebo (47% olive oil, 25% rapeseed oil, 25%
soy oil and 3% fish oil) for 9 weeks, culminating in a
period of intense stress. While there were no significant
differences between groups in epinephrine, cortisol, glu-
cose or insulin, DHA significantly reduced plasma nore-
pinephrine (NE) concentrations from baseline (-13%, p <
0.03). This reduction corresponded with a 78% increase
in the ratio of epinephrine (E) to NE in the DHA group (p
< 0.02). The higher E:NE ratios were interpreted as a
favourable adaptive response to stress. This claim was sub-
stantiated by citations of studies which reported a failure
to normalise the E:NE ratio during psychological stress
observed in patients with duodenal ulcer. This ratio is
believed to be protective as it has been associated with
lower death rates in 412 older men. Thus, the authors con-
cluded, a possible adaptive mechanism for DHA during
stress may be to regulate the E:NE ratio.
Another possible mechanism whereby omega-3 fatty
acids may be protective in stress is by modulation of
proinflammatory cytokines. Maes and Christophe et al [9]
found that exam stress in 27 university students signifi-
cantly increased the stimulated production of many
proinflammatory cytokines ex vivo. Subjects with low
serum omega-3 fatty acid levels had significantly higher
stimulated production of interleukin-6 at baseline com-
pared with the subjects with high serum levels (p = 0.026)
and a trend towards a significant difference during aca-
demic stress (p = 0.1). Stimulated production of inter-
feron-γ and tumour necrosis factor-α was significantly
greater in subjects with low serum omega-3 fatty acids (p
= 0.02). The higher serum omega 3 levels were believed to
be protective in academic stress because they were associ-
ated with lower levels of pro-inflammatory cytokines
The primary aim of the present study is to investigate
whether manipulation of dietary fats has an effect on per-
ceived stress, as measured by the Perceived Stress Scale
(PSS). The hypothesis is that DHA will ameliorate stress in
moderate to highly stressed university staff.
Methods
A small intervention study was nested within a larger pro-
spective cross sectional study. Figure 1 illustrates the
research design. The cross sectional study compared three
stress measures, and correlated the respective measuresNutrition Journal 2004, 3:20 http://www.nutritionj.com/content/3/1/20
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with measures of mood and dietary fats intake [10]. This
was repeated after a 10-week interval.
Moderately stressed subjects were randomised into a 6-
week intervention study. The nutritional intervention
study was designed as a double blind randomised pla-
cebo-controlled clinical trial (pilot), involving three
groups. The three groups were (1) active (1.5 g/d DHA
from fish oil); (2) placebo (olive oil); and (3) control (no
treatment). The supplementation period was 6-weeks.
Study Population
All procedures and processes were subject to the prior
approval of the Human Research Ethics Committee at
Southern Cross University.
Sample size
A power calculation was conducted using the variability
data on the PSS [11]. The α and β values were set at 0.05
and 0.8, respectively. The resulting sample size require-
ment was for 50 subjects in each arm to demonstrate a
change of 20%, 70 subjects to demonstrate a change of
15% and 175 subjects to demonstrate a change of 10%.
For logistical reasons (the research was part of an honours
project), the sample size for the study was chosen to be 15
subjects in each arm. Whilst inadequately powered, it was
hoped that there were enough subjects to provide data
that may indicate data trends.
Recruitment
All staff members of Southern Cross University were
invited via intra-staff email to participate in the study on
the effects of dietary fats in stress. Staff that responded to
the initial recruitment email had the questionnaire per-
sonally delivered. They were instructed to complete the
questionnaire and return it via internal mail. Staff mem-
bers were contacted by phone and invited to participate in
the nutritional intervention study if the score on the PSS
was greater than or equal to 17.
Time course for recruitment and study
Recruitment for the intervention study commenced in
June 2002 and was conducted over a 4-week period.
Scores from the PSS at Time 1 formed the screening for the
intervention study. The PSS was re-administered at base-
line. The supplementation period commenced at the end
of June and was completed by mid July 2002. Time 2
questionnaires were then sent out to all subjects that had
participated at Time 1. Questionnaires were returned and
scored in September 2002.
Inclusion/exclusion criteria
Subjects were included if they were 18–60 years, had not
taken a course of fish oil in the past three months,
refrained from taking other nutritional supplements and/
or aspirin and from radically changing their diet for the
duration of the trial, and had a normal physical examina-
tion. Subjects were excluded for medical history of coro-
nary heart disease, any type of clotting disorder, clinically
diagnosed depression, psychiatric history, diabetes melli-
tus, or in female subjects, pregnancy or lactation. Suitable
candidates undertook a brief clinical assessment.
Randomisation and blinding
Subjects gave informed consent for the study and were
subsequently randomised into two groups. A computer
program was used to generate the stratified randomisation
schedule. The investigators involved with the study had
no knowledge of the details or results of randomisation,
the study participants had no knowledge of the group to
which they had been allocated, all investigators and stat-
isticians associated with the research were blinded regard-
ing ongoing results.
The Nutritional Intervention
Each capsule contains 1000 mg tuna oil, with 10 mg d-
alpha-Tocopherol (vitamin E). The tuna oil was standard-
ised to contain docosahexaenoic acid (DHA) 252 mg per
1000 mg, and eicosapentaenoic acid (EPA) 60 mg per
1000 mg oil. The placebo capsules contained 1000 mg
olive oil, consisting predominantly of monounsaturated
A synoptic overview of the research design showing the  smaller intervention study nested within the larger cross sec- tional study Figure 1
A synoptic overview of the research design showing 
the smaller intervention study nested within the 
larger cross sectional study. Note: PSS = Perceived 
Stress Study [11]; VAS = visual analogue scale; OSI-R = 
Occupational Stress Inventory-Revised [21]; PANAS=Posi-
tive and Negative Affect Scales [22].
1. Cross Section Study (n=95)
    PSS PSS
   VAS    VAS
  OSI-R  OSI-R
PANAS    PANAS
   Nutritional    Nutritional 
Assessment Assessment
              Time 1 Time 2 
  10 week interval 
 2. Intervention study (n=30)
PSS 6 weeks
 baseline     supplementationNutrition Journal 2004, 3:20 http://www.nutritionj.com/content/3/1/20
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Flow of participants through each stage of the recruitment process and intervention study Figure 2
Flow of participants through each stage of the recruitment process and intervention study.
Assessed for eligibility 
n= 93 
Excluded n=65
1. Scores < 17 on PSS n=47
2. Not  meeting eligibility
criteria n=9 
3. Refused to cease all other 
supplements for trial
duration n=7 
4. Medical reasons n=2
Randomised
n=30
Active (fish oil)
n=16
1) Received allocated 
intervention n=16
2) Did not receive allocated
intervention n=0
1) Received allocated 
intervention n=14
2) Did not receive allocated
intervention n=0
Placebo (Olive oil) 
n=14
1) Lost to follow up n=1
Reason:  did not return 
questionnaire at Time 2 
2) Discontinued intervention n=4 
Reasons: Illness n=3 
Difficulty swallowing n=1
1) Lost to follow up n=1
Reason: did not return 
questionnaire at Time 2. 
2) Discontinued intervention n=1.
Reason: illness
Analysed n=16 Analysed n=14Nutrition Journal 2004, 3:20 http://www.nutritionj.com/content/3/1/20
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fatty acids. The placebo capsules were identical to the
DHA capsules in every way, including size, shape, colour
and smell.
There was a 2-week wash out period prior to the com-
mencement of the supplementation period that applied
to subjects taking any form of natural or complementary
medicine. All subjects were instructed to take 3 capsules
with breakfast and 3 for dinner for 6 weeks.
Compliance was measured by collecting the bottles with
any remaining supplements at the completion of the
study. The number of remaining supplements was divided
by the total number of supplements dispensed. Less than
85% compliance resulted in the withdrawal of subject
data from analysis.
Outcome
The primary outcome was the differences between groups
in changes over time in perceived stress, as measured by
the Perceived Stress Scale (PSS) [11]. The PSS-10 consists
of 10 questions designed to measure subjective appraisal
of life stress, taking into account appraisal of the ability to
cope with the stress. It has adequate reliability and validity
as a stress appraisal (perceived stress) measure [12]. Scores
on the PSS have been correlated with other mental and
physical health outcomes [13].
Statistical (multi-level) analysis
A two-level structure was used, where level-one units were
measurement occasions, consisting of Time 1 and Time 2.
Level-two units were the treatment groups, consisting of
T1 =the group of subjects that did not go into the interven-
tion study; T2 = the placebo (olive oil) group and T3 = the
active (fish oil) group.
Results
Study population
Response rate to the recruitment email was 13.6% of full-
time equivalent university staff. The response rate for the
return of personally delivered questionnaires was 85%.
The flow of participants through the intervention study is
given in figure 2. There were 47 staff members that scored
≥ 17 on the PSS. After the phone screen, 39 staff members
were invited for an interview, which involved further
inclusion/exclusion criteria, a clinical assessment, and
obtaining informed consent.
A further 11 potential subjects were excluded as a result of
the interview process; 9 because they did not want to cease
other complementary medicines for the duration of the
trial, 1 because of positive findings in the clinical
assessment and 1 was a female subject still occasionally
lactating.
Withdrawals
A high percentage (30%) of subjects that began the inter-
vention study were withdrawn; 3 subjects were lost to fol-
low-up and 6 discontinued intervention; 5 due to illness
related reasons and 1 because taking the supplements
caused discomfort with swallowing. This resulted in 70%
(n = 21) of subjects that commenced the trial participated
until completion of the trial.
Multilevel analysis uniquely allows the use of unbalanced
data sets. The variance component model using restricted
maximum likelihood estimation was used in the hierar-
chical model building strategy. Absent data were assumed
to be 'missing at random', implying that the reason for the
missing data is not relevant to the phenomena being
investigated [14].
Randomisation
The success of randomisation was verified by dividing the
subjects into groups to assess whether the distribution of
group characteristics was evenly balanced. The group was
divided by age, gender, BMI and gender and is given in
table 1. The randomisation process resulted in an uneven
distribution of group characteristics according to occupa-
tion level and gender. The numbers and proportions of
the distribution of staff by occupation level are provided
in table 2. The majority, 71%, of the staff randomised into
the placebo group were administration staff, while the
fish oil group was fairly evenly distributed. In addition,
males seem to be under-represented in the placebo group.
These frequencies and distributions are not outside the
range of expected results from the randomisation process.
The main concern is that the numbers are very low in
some groups. For instance, 3 male subjects in the placebo
group and 4 academic staff in the placebo group may not
be enough to be sensitive to significant effects, increasing
the risk of a Type II error. However, the results of multivar-
iate analysis of variance found that gender and
occupational status did not have any effects on perceived
stress. Therefore, the unbalanced distribution of group
characteristics was not relevant.
Preliminary and multilevel analysis
Correlations between PSS scores at Time 1 and baseline
were high (0.9, p < 0.05) and there was no significant dif-
ference between group means on paired-samples t-tests.
Therefore all subsequent analysis treated Time 1 PSS as
baseline scores. Preliminary analysis involved testing for
any main effects of occupation level, gender and age on
the various stress measures. A two-way between-groups
multivariate analysis of variance was used to test for sig-
nificant interactions between the active (fish oil) and pla-
cebo (olive oil) groups over time. Age, gender and
occupation levels were all added to the model with noNutrition Journal 2004, 3:20 http://www.nutritionj.com/content/3/1/20
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significant effects. Therefore all models were reduced to
test for the two main effects of treatment and time on per-
ceived stress.
When the fish oil group was compared with the placebo
group (olive oil), variance components analysis found no
difference. No treatment effect was found but there was a
trend towards an effect for the fish oil group (Wald statis-
tic = 1.24). There was a main effect for time in both
groups.
Because of the very small numbers of subjects on the
study, results of the comparison between the fish oil and
the placebo groups were then compared with the group of
subjects that did not participate in the intervention study.
Means and standard deviations for the three groups on the
PSS are given in table 3. The means were much higher for
subjects on the intervention study. A hierarchical model,
given in table 4, investigated the effects of time, treatment
and the interaction of time on treatment for the three
treatment groups, where T1 = no treatment, T2 = placebo
(olive oil), and T3 = active (fish oil).
The effects of time were significantly greater for subjects
on the intervention study. There was a significant effect of
treatment in the respective active and the placebo groups.
Once the effects of time were accounted for, only the fish
oil group estimated means were significantly different.
The changes in the group means over time are provided in
table 5 and illustrated in figure 3. There were substantial
changes on the PSS for the two groups in the intervention
study over time, but the changes in the no-treatment
group were not different over time.
The change over time in PSS means were not the same for
the two groups in the intervention study. Inclusion in the
fish oil group predicted a larger reduction in estimates of
perceived stress than the placebo group. Estimated means
at Time 2 on the PSS were 17.4 for the fish oil group,
where those for the placebo group were 20.6.
The within-group changes over time are given in table 6.
The changes over time were significant for both the pla-
cebo and fish oil groups but not the no-treatment group.
Table 1: Distribution of group characteristics for subjects randomised into intervention study.
Treatment group
Control: no-treatment Placebo: olive oil Active: fish oil
Mean SD Mean SD Mean SD
Age 44.18 8.127 44.43 9.387 40.69 7.391
Gender .74 .443 .79 .426 .63 .500
Body Mass Index .00 .00 28.051 9.2384 26.684 5.8819
Occupation Status .40 .494 .29 .469 .56 .512
Note: Dummy variables given to categorical variables: gender is coded 1 = female and 0 = males, and occupation status is coded 0 = administration 
staff and 1 = academic staff.
Table 2: Distribution of staff by occupation and gender between 
the three treatment groups at baseline.
Control Placebo Active
No-treatment Olive Oil Fish Oil
n% n % n %
Academic 26 40 4 29 9 56
Administration 37 60 10 71 7 44
Total 63 100 14 100 16 100
Male 17 26 3 21 6 38
Female 46 74 11 79 10 63
Total 63 100 14 100 16 100
Note: % = relative proportion for each subcategory (occupation and 
gender), n = number of subjects
Table 3: Means and standard deviations for the three groups on 
the PSS
No-treatment Placebo (olive oil) Active (fish oil)
Mean (SD)M e a n  ( SD)M e a n  ( SD)
n 63 14 16
PSS 15.83 (4.79) 23.93 (2.62) 23.94 (4.33)
Note: n = number of subjectsNutrition Journal 2004, 3:20 http://www.nutritionj.com/content/3/1/20
Page 7 of 10
(page number not for citation purposes)
The difference between the groups in the changes over
time are given in table 7. The differences between the fish
oil group and the no-treatment group is the only between-
group difference to reach statistical significance (p < 0.05).
The change over time in the placebo group was not signif-
icantly different from those in the no-treatment group.
Changes in the placebo group over time were also not sig-
nificantly different from changes in the fish oil group over
time.
Discussion
There were significant reductions in stress for both the fish
oil and the placebo (olive oil) groups from baseline (both
p < 0.05). The stress reduction for the fish oil group was
significantly different from the no-treatment controls (p <
0.05). The stress reduction in the placebo group was not
significantly different from the no-treatment controls. The
fish oil group had more substantial stress reductions than
the olive oil group, but the differences between the fish oil
and the placebo groups did not reach statistical
significance.
All subjects taking the nutritional intervention reported
significantly less perceived stress at Time 2 (p < 0.05).
Arguably, the key factor influencing these results is 'regres-
sion to the mean', an effect that may have been
exaggerated by methodological limitations such as tim-
ing, a large placebo effect, and the possibility that the
placebo was not a true placebo. These issues are discussed
in the following sections.
Statistical regression
Perhaps staff applied and were selected for the interven-
tion study at a time when their stress levels were peaking.
If this were the case, 'regression to the mean' predicts that
stress levels would decrease. Factors which would exagger-
ate this effect are the difference in the means between the
groups on the intervention study and the no-treatment
Table 4: Parameter estimates for models of variance components, time, treatment (T1 and T2) and interaction (of time on 
treatment) main effects on the Perceived Stress Scale (PSS) group means.
Variance Components Time Main Effects Treatment Main Effects Interaction Main Effects
Fixed effects Coeff. (S.E.) Coeff. (S.E.) Coeff. (S.E.) Coeff. (S.E.)
β Constant 17.639 (0.533) 18.444 (0.597) 16.479 (0.598) 15.836 (0.614)
Time -1.999 (0.669)* -2.223 (0.665)* -0.500 (0.770)
T2 6.958 (1.241)* 8.092 (1.441)*
T3 5.372 (1.164)* 8.101 (1.365)*
T2 × time -2.786 (1.679)
T3 × time -6.059 (1.554)*
Random effects
Subject level residual 
variance
15.498 (4.260) 16.639 (4.200) 8.226 (3.063) 9.867 (2.956)
Time level residual 
variance
18.496 (3.115) 16.599 (2.801) 16.721 (2.801) 13.930 (2.334)
-2 log likelihood 1020.264 1011.772 974.964 960.204
* Denotes significance (Wald statistic ≥ 1.96, where p ≤ 0.05). Note: T2 = olive oil group, T3 = fish oil group, Coeff. = coefficient, S.E. = standard 
error, -2 log likelihood statistic = -2LL.
Table 5: Predicted changes over time in estimates of Perceived Stress Scale (PSS) means for each treatment group, 95% confidence 
intervals, and chi square value.
Control Placebo Fish oil
Estimate -0.500 -3.285 -6.559
95% CI sep 1.509 2.923 2.646
95% CI joint 2.152 4.170 3.755
Chi square 0.421 4.852* 23.590*
* significance determined by chi sq ≥ 3.84, the critical value of chi square for df = 1 when p ≤0.05. Note: 95% CI sep = 95% confidence interval 
considering each item separately, 95% CI joint = 95% confidence interval, considering the estimates of the three treatment groups collectively, df = 
degrees of freedomNutrition Journal 2004, 3:20 http://www.nutritionj.com/content/3/1/20
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controls, and the study time course corresponding with
the mid-year break.
Because only 30 out of a possible 47 candidates were ran-
domised into the intervention study, the 17 potential can-
didates remaining in the group receiving no intervention
were thought to increase the mean of the no-treatment
group. That is, 37% of the no-treatment group had high
scores on the PSS (≥ 17). Therefore, this group was consid-
ered a potential control group for the intervention study.
The time course of the study may have noticeably influ-
enced the regression to the mean. The academic year at
Southern Cross University consists of two semesters. This
study commenced mid-way through the first semester
(Time 1). Questionnaires were reissued at the beginning
of the second semester (Time 2), immediately after the
mid-year break. Staff may generally have been more
relaxed and less stressed after the break. The variation of
stress levels associated with time may have been
minimised if Time 2 had been at mid-semester 2, a time
that corresponds more closely with Time 1.
Evidence of a treatment effect beyond statistical regression
will be demonstrated in the between-group differences.
The only such difference was between the fish oil group
and the no-treatment controls. This evidence supports the
hypothesis that fish oil ameliorates chronic stress.
Methodological limitations
The present study has several important limitations,
including (1) selection bias (2) unsuccessful blinding (3)
inadequate power and (4) the possibility of an active
effect from the 'placebo'.
Sampling bias
Invariably, recruitment involving self-selection entails
some degree of selection bias [15]. In this instance, the
advertisement was aimed at university staff interested in
stress research involving the beneficial omega-3 fatty
acids. Staff may have excluded themselves for weight-
watching reasons, or included themselves because they
were interested in the intervention. Perhaps very stressed
and/or busy staff did not apply, or perhaps staff that were
not stressed did not apply. Because the study ran into the
mid year break, perhaps staff did not apply because of
issues relating to availability during the break.
Power
While the results demonstrated a strong trend towards a
difference between the fish oil and the olive oil groups,
this difference failed to reach statistical significance with
the current sample size. Post-hoc power calculations were
conducted using the PSS means and standard deviations.
The study had 90% power to find a 20% difference
between the fish oil and the placebo groups, and only
40% power to find a difference of 10% significant. The
study was underpowered to find the difference between
the groups statistically significant.
Blinding
Although the capsules appeared in every way identical,
there was one distinct difference. The fish oil capsules
were often accompanied by very mild gastrointestinal dis-
turbances in the form of a slight after taste in the mouth,
which was unmistakably fishy. All the subjects taking the
Changes over time in predicted means on the Perceived  Stress Scale (PSS) for the three treatment groups Figure 3
Changes over time in predicted means on the Perceived 
Stress Scale (PSS) for the three treatment groups.
Table 6: Predicted means and 95% confidence intervals of the 
Perceived Stress Scale (PSS) for the treatment groups over 
time.
Control Placebo Fish oil
Time 1
Mean 15.836 23.929 23.938
95% CI sep 1.203 2.555 2.390
95% CI joint 1.716 3.645 3.409
Time 2
Mean 15.337 20.643* 17.379*
95% CI sep 1.416 2.725 2.455
95% CI joint 2.021 3.888 3.502
Note: 95% CI sep = 95% confidence interval considering each item 
separately, 95% CI joint = 95% confidence interval, considering the 
estimates of the three treatment groups collectively. *denotes 
significant difference from baseline (p < 0.05).
MEASURE:  PSS  Perceived Stress Scale
time
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fish oil suspected as much because they had the taste of
fish in their mouth after ingestion of the capsules.
Interestingly, half (50%) the subjects taking the placebo
during this study also believed they were taking the active
because they 'felt better'. The placebo group did actually
report significantly less stress levels. This effect may be due
regression to the mean, as previously discussed. Other fac-
tors that must be considered are the 'placebo effect' and
the possibility of an active effect from the placebos.
The placebo effect
Half (50%) of the subjects taking the placebo believed
themselves to be taking the active. If these subjects
believed in the treatment and expected to benefit from it,
then it is likely they reported the improvements, which
may have influenced the mean of the group. If half the
group were reporting an exaggerated stress reduction, then
the mean of the group would show a trend towards a treat-
ment effect. Indeed, this was observed: The placebo group
demonstrated significant stress reduction; however, the
change over time was not significantly different from
reductions observed in the no-treatment controls.
Perhaps the most unbiased way to estimate true placebo
effects is to observe the difference between a placebo
group and a group of no-treatment controls in a three-arm
clinical study [16]. In the present study, the change over
time for the placebo group, like the fish oil group, was sig-
nificant (p < 0.05), where the change over time for the no-
treatment controls was not significant. This apparent
placebo effect, however, may have been inflated by statis-
tical regression or an active effect from the placebo.
The placebo
The use of olive oil as a placebo is not uncommon in
essential fatty acid research [17]. However, olive oil may
not be an inert substance in brain lipid chemistry. Oleic
acid, the major lipid in olive oil, is related to an endog-
enous sleep-inducing substance. Isolation of a chemical
from the cerebrospinal fluid of sleep deprived cats, led to
its identification as cis-9,10-octadecenoamide (oleamide),
an analogue of 9-octadecenoic acid (oleic acid) [18].
Oleamide, but not oleic acid, was found to improve the
action of serotonin (5-hydroxytryptamine), which
implies a role for this molecule in mood, alertness and
sleep [19]. Cell membranes have been shown to catalyse
the synthesis of oleamide from oleic acid [20]. In addi-
tion, the rat brain demonstrated control of increased lev-
els of cis-9,10-octadecenoamide (oleamide) by
conversion into oleic acid [18]. Understanding of the lipid
chemistry involved with the neuromodulation of sleep
and mood is still incomplete. However, the assumption
that oleic acid is neutral in lipid neurochemistry is
questionable.
The issue of a correct choice of placebo for essential fatty
acid research is difficult. Most studies use omega-6 rich
oil, such as corn oil, soy oil, or safflower seed oil. How-
ever, this practice is not completely unbiased as the
omega-6 oil competes with omega-3 fatty acids for metab-
olism. Given in high enough doses, the omega-6 oils will
overwhelm delta-6 desaturase and inhibit the metabolism
of the omega-3 fatty acids.
This methodology results in a systematic measurement
error, where the omega-3 metabolism in the placebo
group may be suppressed. Further, the placebo is not a
true placebo if it has a specific effect on the measurement
outcome. Between-group differences in these studies may
be enhanced. Alternatively, soy oil has been shown to
increase omega-3 levels in omega-3 deficiency. As the reg-
ulation of the end products of n-3:n-6 blood levels is com-
plex and not fully understood, it is probably best to avoid
using these fatty acids as a placebo. This practice may
increase the variance in the measurement error to an
unknown extent. The monounsaturated fatty acid found
in olive oil was chosen here to avoid further imbalances
between the essential fatty acids.
Table 7: Estimated between-group differences in changes over time for predicted means on the Perceived Stress Scale (PSS), with 
confidence intervals and chi square statistic.
Placebo vs Control Fish oil vs Control Fish oil vs Placebo
Estimate 2.786 6.059 3.273
95% CI sep 3.289 3.046 3.943
95% CI joint 4.692 4.345 5.625
Chi square 2.754 15.193* 2.647
* Significance determined by observed value of chi sq ≥ 3.84, the critical value of chi square for df = 1 when p ≤ 0.05 Note: 95% CI sep = 95% 
confidence interval considering each item separately, 95% CI joint = 95% confidence interval, considering the estimates of the three treatment 
groups collectively, chi sq = chi square, vs = versus, the difference between groupsPublish with BioMed Central    and   every 
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Conclusions
Perceived stress was significantly reduced from baseline
after 6 weeks supplementation with 1.5 g/d DHA from
fish oil (p < 0.05). Furthermore, the difference was signif-
icant compared with no-treatment controls (p  < 0.05).
The placebo group also demonstrated significant reduc-
tions in perceived stress compared to baseline levels (p <
0.05). However, when compared with the no-treatment
control group, the differences in perceived stress were not
significant for the placebo group.
The study may have demonstrated an exaggerated regres-
sion to the mean due to its timing, a strong placebo effect
or the placebo itself may have had an active effect. The
question that olive oil may have a subtle but protective
effect in stress has nevertheless been raised. Perhaps 6 g
per day of olive oil was not sufficient dietary intake to find
a difference between the placebo and no-treatment con-
trols significant, especially with such a small sample.
This research has provided preliminary findings suggest-
ing that DHA ameliorates perceived stress. Future research
is required to conclusively substantiate the ameliorating
effects of DHA in stress, and further investigate the role of
olive oil and/or other dietary fats in stress reduction.
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